These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29771963)

  • 1. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
    PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
    Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
    Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
    Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of growth differentiation factor-15 in heart failure among whole ejection fraction phenotypes.
    Lyu L; Xu J; Xv C; Xiao H; Liu Z; He Y; Gao W; Hao B; Liu H
    ESC Heart Fail; 2024 Aug; 11(4):2295-2304. PubMed ID: 38641904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study.
    Dallmeier D; Brenner H; Mons U; Rottbauer W; Koenig W; Rothenbacher D
    Clin Chem; 2016 Jul; 62(7):982-92. PubMed ID: 27197673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Yang J
    Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Whooley MA
    Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure.
    Lok DJ; Klip IT; Lok SI; Bruggink-André de la Porte PW; Badings E; van Wijngaarden J; Voors AA; de Boer RA; van Veldhuisen DJ; van der Meer P
    Am J Cardiol; 2013 Sep; 112(6):831-7. PubMed ID: 23820571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS.
    Zelniker TA; Jarolim P; Silverman MG; Bohula EA; Park JG; Bonaca MP; Scirica BM; Morrow DA
    Clin Chem Lab Med; 2019 Jun; 57(7):1084-1092. PubMed ID: 30710475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
    McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
    Dubin R; Li Y; Ix JH; Shlipak MG; Whooley M; Peralta CA
    Am Heart J; 2012 Feb; 163(2):274-9. PubMed ID: 22305847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
    Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor-15 and routine laboratory parameters are associated with one-year mortality in patients with end-stage heart failure undergoing heart transplantation evaluation.
    Szczurek-Wasilewicz W; Warmusz O; Skrzypek M; Karmański A; Jurkiewicz M; Wyrobiec P; Gąsior M; Szyguła-Jurkiewicz B
    Kardiol Pol; 2024; 82(7-8):741-748. PubMed ID: 38845423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Biomarkers of Myocardial Injury and Systemic Inflammation and Risk of Incident Ventricular Arrhythmia.
    Sourour N; Riveland E; Næsgaard P; Kjekshus H; Larsen AI; Røsjø H; Omland T; Myhre PL
    JACC Clin Electrophysiol; 2024 Sep; 10(9):2021-2032. PubMed ID: 38904572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
    Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
    ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.